The FDA has approved DaTscan (Ioflupane I 123 Injection, from GE Healthcare) for use with single photon emission computed tomography (SPECT) imaging, for the detection of dopamine transporters (DaT) ...
GE Healthcare announced that DaTscan (Ioflupane I 123 Injection) is available for the detection of dopamine transporters (DaT) in the brains of adult patients with suspected Parkinsonian syndromes.
January 17, 2011 — GE Healthcare has announced Food and Drug Administration (FDA) approval of ioflupane iodine-123 injection (DaTscan), a contrast agent for use with single-photon emission computed ...
The DaTscan, a special type of dopamine transporter imaging brain scan, may help doctors predict how a newly diagnosed patient’s Parkinson’s disease will progress, researchers from the University of ...
Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
William Tank Hill used to be a professional welterweight fighter. Today he's fighting Parkinson's disease. Debora Bergstrom has it, too. The mother of three battles tremors, balance problems and ...
Guelph Medical Imaging (GMI) says a new exam now available at its clinic on Dawson Road is able to definitively tell patients if they have Parkinsonian Syndromes, such as Parkinson’s Disease. DaTscan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results